Pioneering therapeutics to turn every IVF attempt into a success story

1 in 6

couples worldwide
struggle with infertility

7 in 10

of IVF cycles fail
in women aged under 35

9 in 10

of IVF cycles fail
in women aged between 40 and 42

Poor egg quality is the main reason IVF fails (click to see why)

Chromosome segregation errors arise as the egg matures and eliminates half of the DNA in preparation for fertilisation. These defects accumulate with age and drive the sharp drop in IVF success after 35 years.

Our solution

At Ovo Labs, we are developing therapeutics that boost egg quality to enhance IVF success. Our technology aims to extend the timeline when the chances of conception are high. We are currently advancing three such egg rejuvenation therapeutics through preclinical development toward the clinics.

Together, these therapeutics have the potential to increase IVF success rates by 20-30% for women below 35 and by 3-5 times for women aged 35-45.

Learn More

Pioneered by world-leading fertility experts and biotech strategists

Ovo Labs was co-founded by a team of pioneering experts in female fertility, whose groundbreaking research over the past decades has led to landmark publications and prestigious awards for advancing our understanding of age-related fertility decline in women.

Prof. Melina Schuh

Dr Agata Zielinska

Dr Oleksandr Yagensky

Learn more